Bionik Laboratories announced the appointment of Dr. Eric Dusseux, a director of the Company since July 2017, as CEO.
Bionik Laboratories (OTCQB:BNKL) announced the appointment of Dr. Eric Dusseux, a director of the Company since July 2017, as CEO.
As quoted in the press release:
Dr. Dusseux is a proven executive who has spent the past 15 years focused on helping companies in the healthcare sector develop and execute strategic growth and commercialization plans. Peter Bloch will continue to serve Bionik in the capacity as Chairman of the Board of Directors of the Company and will consult with the Company during the management transition.
“We are delighted that Eric has chosen to accept the role of Chief Executive Officer at Bionik,” said Mr. Bloch. “His proven entrepreneurial ability to drive commercialization and growth strategy in domestic and international markets, and his experience in building and leading strategic alliances will be significant assets for Bionik.